These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 25104195

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
    Shanmugan S, Arrangoiz R, Nitzkorski JR, Yu JQ, Li T, Cooper H, Konski A, Farma JM, Sigurdson ER.
    Ann Surg Oncol; 2012 Jul; 19(7):2178-85. PubMed ID: 22395978
    [Abstract] [Full Text] [Related]

  • 3. Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation?
    Bampo C, Alessi A, Fantini S, Bertarelli G, de Braud F, Bombardieri E, Valvo F, Crippa F, Di Bartolomeo M, Mariani L, Milione M, Biondani P, Avuzzi B, Chiruzzi C, Pietrantonio F.
    Oncology; 2013 Jul; 84(4):191-9. PubMed ID: 23328390
    [Abstract] [Full Text] [Related]

  • 4. Consolidation mFOLFOX6 Chemotherapy After Chemoradiotherapy Improves Survival in Patients With Locally Advanced Rectal Cancer: Final Results of a Multicenter Phase II Trial.
    Marco MR, Zhou L, Patil S, Marcet JE, Varma MG, Oommen S, Cataldo PA, Hunt SR, Kumar A, Herzig DO, Fichera A, Polite BN, Hyman NH, Ternent CA, Stamos MJ, Pigazzi A, Dietz D, Yakunina Y, Pelossof R, Garcia-Aguilar J, Timing of Rectal Cancer Response to Chemoradiation Consortium.
    Dis Colon Rectum; 2018 Oct; 61(10):1146-1155. PubMed ID: 30192323
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [A CR case of colorectal cancer given 39 courses of FOLFOX].
    Kobayashi K, Kaneko M, Fujiwara M, Otsubo M, Ogura S, Isaka T, Imai N, Naota H, Taniguchi K.
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):135-8. PubMed ID: 19151580
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Accuracy of positron emission tomography/computed tomography and clinical assessment in the detection of complete rectal tumor regression after neoadjuvant chemoradiation: long-term results of a prospective trial (National Clinical Trial 00254683).
    Perez RO, Habr-Gama A, Gama-Rodrigues J, Proscurshim I, Julião GP, Lynn P, Ono CR, Campos FG, Silva e Sousa AH, Imperiale AR, Nahas SC, Buchpiguel CA.
    Cancer; 2012 Jul 15; 118(14):3501-11. PubMed ID: 22086847
    [Abstract] [Full Text] [Related]

  • 12. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial.
    Rödel C, Liersch T, Becker H, Fietkau R, Hohenberger W, Hothorn T, Graeven U, Arnold D, Lang-Welzenbach M, Raab HR, Sülberg H, Wittekind C, Potapov S, Staib L, Hess C, Weigang-Köhler K, Grabenbauer GG, Hoffmanns H, Lindemann F, Schlenska-Lange A, Folprecht G, Sauer R, German Rectal Cancer Study Group.
    Lancet Oncol; 2012 Jul 15; 13(7):679-87. PubMed ID: 22627104
    [Abstract] [Full Text] [Related]

  • 13. [A case of unresectable rectal cancer with severe pelvic infiltration responding to FOLFOX].
    Yamazoe S, Yamaguchi K, Terasawa H, Ojima T, Tsujimura H, Shimomura T.
    Gan To Kagaku Ryoho; 2011 Jan 15; 38(1):125-8. PubMed ID: 21368473
    [Abstract] [Full Text] [Related]

  • 14. Induction Chemotherapy Reduces Patient-reported Toxicities During Neoadjuvant Chemoradiation with Intensity Modulated Radiotherapy for Rectal Cancer.
    Ng SY, Colborn KL, Cambridge L, Cercek A, Reidy-Lagunes DL, Segal N, Stadler Z, Saltz LB, Paty PB, Guillem J, Weiser MR, Nash G, Garcia-Aguilar J, Goodman KA.
    Clin Colorectal Cancer; 2019 Sep 15; 18(3):167-174. PubMed ID: 31104990
    [Abstract] [Full Text] [Related]

  • 15. [A case report of advanced rectal cancer showing a pathological complete response by neo-adjuvant FOLFOX chemotherapy].
    Murata A, Inoue T, Maeda K, Noda E, Nagahara H, Kubo N, Tanaka H, Muguruma K, Yamada N, Ohira M, Hirakawa K.
    Gan To Kagaku Ryoho; 2010 Nov 15; 37(12):2623-5. PubMed ID: 21224659
    [Abstract] [Full Text] [Related]

  • 16. The short-term outcomes of induction SOX (S-1 + oxaliplatin) ± cetuximab chemotherapy followed by short-course chemoradiotherapy in patients with poor-risk locally advanced rectal cancer.
    Beppu N, Yoshie H, Kimura F, Aihara T, Doi H, Kamikonya N, Matsubara N, Tomita N, Yanagi H, Yamanaka N.
    Surg Today; 2016 Oct 15; 46(10):1123-31. PubMed ID: 26704191
    [Abstract] [Full Text] [Related]

  • 17. [A case of pathological complete response with neoadjuvant mFOLFOX6 chemotherapy for advanced lower rectal cancer].
    Sueda T, Noura S, Ohue M, Shingai T, Gotoh K, Motoori M, Takahashi H, Kishi K, Marubashi S, Fujiwara Y, Ohigashi H, Yano M, Tomita Y, Ishikawa O.
    Gan To Kagaku Ryoho; 2013 Nov 15; 40(12):1965-7. PubMed ID: 24393981
    [Abstract] [Full Text] [Related]

  • 18. [Value of postoperative adjuvant chemotherapy in locally advanced rectal cancer patients with ypT1-4N0 after neo-adjuvant chemoradiotherapy].
    You KY, Peng HH, Gao YH, Chen L, Zhou GQ, Chang H, Du XJ, Xiao L, Zeng ZF, Wen BX, Liu MZ.
    Zhonghua Zhong Liu Za Zhi; 2013 Sep 15; 35(9):708-13. PubMed ID: 24332061
    [Abstract] [Full Text] [Related]

  • 19. Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer.
    Kim DY, Jung KH, Kim TH, Kim DW, Chang HJ, Jeong JY, Kim YH, Son SH, Yun T, Hong CW, Sohn DK, Lim SB, Choi HS, Jeong SY, Park JG.
    Int J Radiat Oncol Biol Phys; 2007 Feb 01; 67(2):378-84. PubMed ID: 17097835
    [Abstract] [Full Text] [Related]

  • 20. Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fluorouracil and preoperative chemoradiation.
    Calvo FA, Serrano FJ, Diaz-González JA, Gomez-Espi M, Lozano E, Garcia R, de la Mata D, Arranz JA, García-Alfonso P, Pérez-Manga G, Alvarez E.
    Ann Oncol; 2006 Jul 01; 17(7):1103-10. PubMed ID: 16670204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.